Low-Molecular Weight Heparins in Percutaneous Coronary Interventions: Current Concepts, Problems, and Perspectives

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|4|375-386

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.4, 2004-02, pp. : 375-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low molecular weight heparins

By Aguilar O.M.   Kleiman N.S.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 6, 2000-09 ,pp. : 1091-1103

Informa Healthcare

Access to resources Recommend Favorite

Safety Profile of Different Low-Molecular Weight Heparins Used at Therapeutic Dose

By Gouin-Thibault Isabelle  

Drug Safety, Vol. 28, Iss. 4, 2005-01 ,pp. : 333-349

Adis International

Access to resources Recommend Favorite

Costs and Cost Effectiveness of Low Molecular Weight Heparins and Platelet Glycoprotein IIb/IIIa Inhibitors: In the Management of Acute Coronary Syndromes

By Bosanquet N.  

PharmacoEconomics, Vol. 21, Iss. 16, 2003-01 ,pp. : 1135-1152

Adis International

Access to resources Recommend Favorite

Combination of Low Molecular Weight Heparins with Antiplatelet Agents in Non-ST Elevation Acute Coronary Syndromes: An Update

By Cohen M.  

Drugs, Vol. 62, Iss. 12, 2002-01 ,pp. : 1755-1770

Adis International

Access to resources Recommend Favorite

Low molecular weight heparins combined with platelet glycoprotein IIb/IIIa inhibitors in the management of acute coronary syndromes

By Salam Amar M  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1567-1570

Informa Healthcare

Access to resources Recommend Favorite